• Explore /
  • Poster
  • / DNA methyltransferase inhibitor guadecitabine combined with cisplatin and gemcitabine chemotherapy (SPIRE): Randomized expansion phase as neoadjuvant therapy for bladder urothelial carcinoma.

DNA methyltransferase inhibitor guadecitabine combined with cisplatin and gemcitabine chemotherapy (SPIRE): Randomized expansion phase as neoadjuvant therapy for bladder urothelial carcinoma.

Abstract Poster

Authors

null

Simon J. Crabb

Southampton Experimental Cancer Medicine Centre, Southampton, United Kingdom

Simon J. Crabb , Sarah Danson , James WF Catto , Syed A. Hussain , Denise Dunkley , Nichola Downs , Geoff Saunders , Michelle Light , Naveed Sarwar , Deborah Enting , Alison Jane Birtle , Amir El Ghzal , Bernadette Johnson , Robert A Huddart , Gareth Owen Griffiths

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

16332228

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 447)

DOI

10.1200/JCO.2021.39.6_suppl.447

Abstract #

447

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Simon J. Crabb

First Author: Christian Pfister

First Author: Sarah P. Psutka

First Author: Srikala S. Sridhar